APA (7th ed.) Citation

H, Z., Z, Z., J, W., S, W., J, R., M, Z., & M, Y. (2025). Adverse drug reaction assessment of pembrolizumab in cervical cancer treatment: A real-world pharmacovigilance study using the FAERS database. Frontiers in immunology, 16, 1582050. https://doi.org/10.3389/fimmu.2025.1582050

Chicago Style (17th ed.) Citation

H, Zhang, Zhou Z, Wang J, Wang S, Ren J, Zhang M, and Yang M. "Adverse Drug Reaction Assessment of Pembrolizumab in Cervical Cancer Treatment: A Real-world Pharmacovigilance Study Using the FAERS Database." Frontiers in Immunology 16 (2025): 1582050. https://doi.org/10.3389/fimmu.2025.1582050.

MLA (9th ed.) Citation

H, Zhang, et al. "Adverse Drug Reaction Assessment of Pembrolizumab in Cervical Cancer Treatment: A Real-world Pharmacovigilance Study Using the FAERS Database." Frontiers in Immunology, vol. 16, 2025, p. 1582050, https://doi.org/10.3389/fimmu.2025.1582050.